Wednesday, 2 October 2013

Serelaxin Boosts Renal Function in HF Patients (CME/CE)

ORLANDO (MedPage Today) -- Chronic heart failure patients on the investigational drug serelaxin showed improved renal blood flow, a small randomized trial found. (Source: MedPage Today State Required CME)

Source: http://www.medworm.com/index.php?rid=7625882&cid=u_0_26_f&fid=38008&url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FHFSA%2F41868

phlebotomy training indianapolis how long is a phlebotomy course how long is the phlebotomy course

No comments:

Post a Comment